SCHEMBL4687484

SCHEMBL4687484

COc1cc(OC[C@@H](C)O)ccc1CNC(=O)c1sc(C)c2c1CC1[C@H]2C1(C)C

nearest known ligand 0.82

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 12/20 0.82
S1PR3 Q99500 3/20 0.62
CACNA1G O43497 7/20 0.58
CACNA1H O95180 7/20 0.58
CACNA1I Q9P0X4 7/20 0.58
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2947804 1.00 S1PR1 (0.82) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2947802 1.00 S1PR1 (0.82) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL4687480 1.00 S1PR1 (0.82) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2944012 0.94 S1PR1 (0.84) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2942570 0.92 S1PR1 (0.81) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2944476 0.92 S1PR1 (0.81) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL1383402 0.91 S1PR1 (1.00) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2947553 0.90 S1PR1 (0.88) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2943601 0.90 S1PR1 (0.88) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2940088 0.89 CACNA1G (0.67) S1PR1S1PR3CACNA1GCACNA1HCACNA1I

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805163-B1 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA[A]PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2008-10-01 EP claimed
EP-1805163-B1 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA[A]PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2008-10-01 EP disclosed